KLF9 and obesity due to melanocortin 4 receptor deficiency: We used this model to evaluate the in vivo effects of Klf9 KO on obesity/adiposity and related parameters including hepatic lipid content, circulating adipokine concentrations, and hepatic and systemic oxidative stress, all of which are considered to positively influence HCC risk.